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Abstract 
Background and Objective:  Periodontitis is a multifactorial disease associated with 
genetic and environmental factors.  Recent reports have shown that single-nucleotide 
polymorphisms (SNPs) are associated with susceptibility to common diseases such as 
not only diabetes and hypertension but also periodontitis.  Although the oral cavity is 
continuously exposed to various pathogenic organisms, the oral conditions are well 
controlled by innate and acquired immune systems.  Antimicrobial peptides (AMPs) 
play an important role in the innate immune system; however, the association of 
AMP-SNPs with periodontitis has not been fully elucidated.  The aim of the present 
study was to investigate the relationship between AMP-SNPs and periodontitis in 
Japanese. 
Methods:  One hundred and five Japanese subjects were recruited, which included 21 
patients with aggressive, 28 with severe, 13 with moderate and 22 with mild 
periodontitis, as well as 21 age-matched healthy controls.  Genomic DNA was isolated 
from peripheral blood in each subject.  Genotypes of four reported SNPs of 
-defensin-1 and lactoferrin genes (DEFB1: rs1799946, rs1800972 and rs11362; and 
LTF: rs1126478) were investigated using the PCR-Invader assay.  Protein levels of 
AMP in gingival crevicular fluid (GCF) were quantified by ELISA. 
Results:  Case-control studies revealed that the -44 CC genotype of DEFB1 
(rs1800972) was associated with severe chronic periodontitis (odds ratio 4.15) and with 
combined severe and moderate chronic periodontitis (odds ratio 4.04).  No statistical 
differences were found in other genotypes.  The -defensin-1 concentrations in GCF 
were significantly lower in the subjects with the -44 CC genotype of DEFB1 than in 
those without this genotype.  No significant differences between GCF concentrations 
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of AMPs and other genotypes were detected. 
Conclusion:  The -44 CC genotype of the -defensin-1 gene (DEFB1 rs1800972) may 
be associated with susceptibility to chronic periodontitis in Japanese. 
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Introduction 
Periodontitis is an inflammatory disease primarily caused by the infection of dental 
plaque microorganisms, followed by periodontal tissue destruction after a continuous 
excessive immune response.  There are many factors that initiate and cause the 
progression of periodontitis, which include not only microbial factors but also other 
local and systemic factors such as age, gender, ethnicity, smoking, lifestyle, stress, 
heredity and systemic diseases.  Thus, periodontitis is considered to be a multifactorial 
disease associated with genetic and environmental factors (1). Genetic factors can 
convey susceptibility to periodontitis and recent reports have shown that 
single-nucleotide polymorphisms (SNPs) are important variations among the genetic 
factors that underlie the host response to diseases (2, 3).  In general, humans have 2 to 
3 million SNPs, which correspond to 0.1% of genomic DNA.  SNPs in non-coding 
regions can affect the regulation of gene expression, and SNPs in coding regions can 
change protein sequences and often give rise to different biological functions.  Many 
basic and clinical studies have shown the relationship between SNPs and susceptibility 
to periodontitis (2-4).  It has been reported that SNPs of interleukin (IL)-1, IL-6, IL-10, 
IL-17, tumor necrosis factor (TNF)- and immunoglobulin G Fc receptors (FcR) may 
be associated with the initiation and progression of periodontitis (5-10).  Our 
collaborating studies reported that vitamin D receptor (VDR) +1056 polymorphisms are 
related to chronic periodontitis (11) and that2 integrin +807 polymorphisms are 
related to drug-induced gingival overgrowth (12). 
The oral cavity is continuously exposed to various pathogenic organisms, but oral 
conditions are well controlled by innate and acquired immune systems.  Innate 
immunity functions in most species, including insects, fungi, plants and mammals, as 
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non-specific host defence at an early stage of microorganism challenge.  
Antimicrobial peptides (AMPs) play an important role in the innate immune system 
and more than 800 AMPs have been identified (13, 14).  Many AMPs such as 
lysozyme, defensin, lactoferrin, histatin, cystatin and calprotectin were found in the 
human oral cavity, and several reports demonstrated the association between 
periodontitis and AMP levels in saliva, gingival tissue or gingival crevicular fluid 
(GCF) (15-17).  We previously reported that the calprotectin level in GCF correlated 
with gingival index in periodontitis patients (18, 19).  It is conceivable that gene 
polymorphisms of AMPs cause differences in the innate immune system and confer 
susceptibility to various infectious diseases.  However, there have been few reports 
concerning the association of AMP-SNPs with periodontitis. 
Human -defensins are small cationic AMPs, and at least four types of -defensin have 
been characterized (20).  -defensin-1 is a prominent molecule of the defensin family 
that is encoded by the DEFB1 gene (21).  SNPs of the DEFB1 gene are located in 
coding and non-coding regions, including the 5’-untranslated region (5’-UTR) and 
3’-UTR (22, 23).  -defensin-1 is expressed in keratinocytes and epithelial cells, and is 
found in the kidney, female reproductive tract, testis, gingival tissue, small intestine, 
large intestine, cornea and mammary gland (22, 24).  Lactoferrin, also known as 
lactotransferrin, is a multifunctional metalloprotein, which is a member of the 
transferrin family (25).  Human lactoferrin is encoded by the LTF gene and SNPs of 
the LTF gene have been identified in both coding and non-coding regions (26).  
Human lactoferrin is produced by mucosal epithelial cells and widely found in various 
secretory fluids, such as milk, saliva, tears, sweat and nasal secretions (25).  In 
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addition, human lactoferrin is produced by secondary granules of neutrophils and is 
released in response to inflammation (27). 
In this study, we analyzed the genotype distributions and allele frequencies of three 
DEFB1 SNPs and one LTF SNP in Japanese periodontitis patients, and then we 
quantified the GCF concentrations of these AMPs in the subjects.  Since SNPs are 
generally associated with ethnicity and geography, this study focused on Japanese 
subjects to determine the relationship between AMP-SNPs and aggressive or chronic 
periodontitis. 
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Materials and Methods 
Subjects and Study Protocol 
The protocol for this study was reviewed and approved by the ethics committee of 
human genome and gene analysis at the University of Tokushima (Approval No. H23-7).  
From subjects who agreed to participate in the study, written informed consent was 
obtained before undergoing periodontal examinations.  Periodontal conditions were 
diagnosed according to the criteria of the 1999 International Workshop for 
Classification of Periodontal Diseases and Conditions (28).  The subjects were divided 
into five groups: aggressive periodontitis (AgP), chronic periodontitis (severe CP, 
moderate CP and mild CP) and age-matched healthy controls, on the basis of clinical 
examinations including probing depth (PD), clinical attachment level (CAL), bleeding 
on probing (BOP) and alveolar bone loss (BL).  The bone loss was assessed at 2 sites 
of a tooth on a radiograph (29).  Exclusion criteria were the presence of systemic 
disease (e.g., diabetes mellitus and kidney disease), drug-induced gingival overgrowth, 
pregnancy, having fewer than 15 teeth and a history of any periodontal therapy within 
the previous 6 months.  In this study, age-matched healthy controls were subjects 
under 35 years old in the case of AgP and more than 40 years old in the case of mild CP, 
both having localized PD ≤ 3 mm and mean BL ≤ 15%.  The AgP group consisted of 
subjects under 35 years old having localized CAL ≥ 5 mm, the severe CP group 
consisted of subjects more than 40 years old having localized PD ≥ 4 mm and mean BL 
≥ 34%, and the moderate CP group consisted of subjects more than 40 years old having 
localized PD ≥ 4 mm and 17% ≤ mean BL ≤ 28%.  One hundred and five Japanese 
subjects were recruited, including 21 with AgP, 28 with severe CP, 13 with moderate CP, 
22 CP controls and 21 AgP controls. 
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Isolation of Genomic DNA and Genotype Determination 
Five milliliters of peripheral blood was obtained from the basilic, cephalic or median 
cubital vein of each subject.  Genomic DNA was isolated from the blood sample and 
the genotypes of the -defensin-1 gene (DEFB1) and the lactoferrin gene (LTF) were 
determined using a PCR-Invader assay by BML Inc. (Saitama, Japan).  The 
PCR-Invader assay was reported previously (30).  In this study, we assayed three 
known SNPs in the 5’-UTR of DEFB1, namely, at positions -52 G/A (rs1799946; a 
guanine to adenine nucleotide mutation), -44 C/G (rs1800972; a cytosine to guanine 
nucleotide mutation) and -20 G/A (rs11362; a guanine to adenine nucleotide mutation) 
from the first AUG codon (31-33).  In addition, we assayed one known SNP of LTF, 
namely, at position 29 in the N-terminal alpha-helical region of human lactoferrin 
(rs1126478; an adenine to guanine nucleotide mutation) (34, 35). 
 
Sampling of Gingival Crevicular Fluid and -defensin-1 Quantification 
Gingival crevicular fluid (GCF) samples were collected according to a previously 
described method (36).  Briefly, before the clinical evaluation including PD and BOP, 
GCF was collected using Periopaper
®
 (Oraflow Inc., New York, NY) from healthy 
gingival crevices or periodontal pockets with periodontitis.  GCF volume was 
determined using Periotron 8000
®
 (Harco Electronics, Winnipeg, MB, Canada).  The 
GCF perfused in paper strips was extracted using 100 μL of 10 mM Tris–HCl buffer 
(pH 7.4) containing 200 μM phenylmethylsulfonyl fluoride.  The amounts of 
-defensin-1 and lactoferrin in GCF samples were determined using enzyme-linked 
immunosorbent assay (ELISA) kits (Human BD-1 ELISA Kit, pink-ONE, KOMA 
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BOTEC Inc., Seoul, Korea; Human Lactoferrin ELISA Kit; HyCult Biotechnology b.v., 
Uden, Netherlands).  The samples were diluted 2- or 10-fold with the dilution buffer of 
each kit and used for the determination of -defensin-1 and lactoferrin according to the 
manufacturers’ instructions.  After the total amounts of -defensin-1 and lactoferrin 
were measured from the standard curve, the -defensin-1 and lactoferrin concentrations 
of GCF samples were obtained as pg or ng/l by adjusting for the GCF volume. 
 
Statistical Analyses 
The distribution of each SNP genotype was evaluated for Hardy-Weinberg equilibrium.  
Statistical analyses were performed using JMP
®
 software (SAS Institute Inc., Cary, 
NC).  The differences in genotype distributions and allele frequencies were tested by 
chi-square tests.  When an expected value in cells was less than five, Fisher’s exact 
tests were used.  Contingency tables (2 x 2) were used for three kinds of comparison: 
AgP vs. AgP control, severe CP vs. CP control, and combined periodontitis (severe CP 
and moderate CPs) vs. CP control.  The strength of the associations was determined 
using odds ratio (OR) calculation and 95% confidence intervals (95% CI).  In the 
ELISA analysis, the relationships between -defensin-1 concentration in GCF and 
DEFB1 genotypes and between lactoferrin concentration in GCF and LTF genotype 
were evaluated using the nonparametric Wilcoxon signed-rank test and Mann-Whitney 
U-test.  A p-value of less than 0.05 was considered to be statistically significant. 
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Results 
Demographics 
Table 1 provides a summary of the demographic and clinical characteristics of the 105 
Japanese subjects in the five groups, consisting of AgP, severe CP, moderate CP, CP 
control and AgP control.  The mean ages of those with severe CP, moderate CP and CP 
control were similar, whereas those with AgP were significantly older than those in the 
AgP control group (p<0.05).  The AgP group showed significantly higher values of BL, 
PPD and BOP than the AgP control.  The severe CP group showed significantly higher 
values of BL, PPD and BOP than the CP control group.  The moderate CP group 
showed a significantly higher value of BL than the CP control.  When the severe and 
moderate CPs were combined (n = 41), higher values of BL, PPD and BOP were 
observed in the combined group than in the CP control group (p<0.01, data not shown). 
 
SNP analysis of DEFB1 and LTF 
We analyzed three SNPs at positions -52 G/A, -44 C/G and -20 G/A in the 5’-UTR of 
DEFB1 and one SNP at position 29, Lys/Arg, in the N-terminal alpha-helical region of 
human lactoferrin.  The genotype distribution of these SNPs did not show any 
significant difference from Hardy-Weinberg equilibrium.  The genotype distributions 
and allele frequencies of DEFB1 and LTF polymorphisms among the five groups are 
summarized in Tables 2 and 3.  The frequency of the -44 CC genotype of DEFB1 was 
higher in the severe CP group (85.7%) and the moderate CP group (84.6%) than in the 
CP control (59.1%).  The frequency of the -44 C allele was higher in the severe CP 
group (92.9%) than in the CP control (79.5%).  In the case of the AgP group, no 
difference of -44 CC genotype or the -44 C allele was observed between AgP and its 
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control.  These results indicate that the frequencies of the -44 CC genotype and the -44 
C allele of DEFB1 were relatively high in cases of chronic periodontitis.  In this study, 
we performed three kinds of comparison: AgP vs. AgP control, severe CP vs. CP control, 
and combined periodontitis (moderate and severe CPs) vs. CP control for 
genotypic/allelic associations of the DEFB1 and LTF polymorphisms.  No significant 
differences were observed in the genotypic/allelic associations of the DEFB1 and LTF 
polymorphisms between AgP and AgP control (Table 2).  However, in the -44 C/G 
polymorphism of DEFB1, statistical significance was observed between the -44 CC 
genotype and severe periodontitis (OR 4.154, 95% CI 1.113–15.304, p<0.05) and 
between the -44 CC genotype and combined periodontitis (OR 4.038, 95% CI 
1.236–13.186, p<0.05).  Statistical significance was also identified between the -44 C 
allele and severe periodontitis (OR 3.343, 95% CI 1.003–11.041, p<0.05).  There were 
no significant differences in the genotypic/allelic associations of other DEFB1 and LTF 
SNPs for severe CP vs. CP control and combined periodontitis vs. CP control (Table 3). 

GCF analysis of -defensin-1 and lactoferrin 
To evaluate the relationship between the genotype and expressions of AMPs in GCF 
samples, 67 GCF samples from 17 subjects and 71 GCF samples from 16 subjects were 
used for the determination of -defensin-1 and lactoferrin, respectively.  As shown in 
Fig. 1A, ELISA analysis revealed that the -defensin-1 concentrations were 
significantly lower in the subjects with the -44 CC genotype than in those without the 
-44 CC genotype, namely, 0.95 ± 0.36 and 1.55 ± 0.63 pg/l, respectively (p<0.05).  
Moreover, the -defensin-1 concentrations in PD ≤ 3 mm were significantly lower in 
the subjects with the -44 CC genotype than in those without it, namely, 1.12 ± 0.43 and 
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2.20 ± 1.22 pg/l, respectively (p<0.05, Fig. 1A).  There were no significant 
differences in PD ≥ 4 mm between the subjects with the -44 CC genotype and those 
without it, with values of 0.86 ± 0.54 and 0.81 ± 0.13 pg/l, respectively (Fig. 1A).  
When the concentrations of lactoferrin in GCF were evaluated, no significant 
differences were observed between the subjects with the GG genotype of LTF and those 
without it, with values of 7.77 ± 2.09 and 8.14 ± 4.85 ng/l, respectively (Fig. 1B). 
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Discussion 
In this study, we investigated the association of four AMP-SNPs with the susceptibility 
to periodontitis in 105 Japanese subjects.  We selected three SNPs in the 5’-UTR of the 
DEFB1 gene (rs1799946, rs1800972 and rs11362) and one SNP in exon 1 of the LTF 
gene (rs1126478).  These SNPs have been considered to be associated with various 
infectious diseases.  DEFB1 gene polymorphisms were reported to be related to 
Pseudomonas aeruginosa airway colonization in cystic fibrosis, oral Candida carriage, 
lepromatous leprosy, HIV infection, Helicobacter pylori-induced gastritis, severe acute 
pancreatitis and dental caries (31, 33, 38-42).  LTF gene polymorphism was reported to 
be related to dental caries (37).  In terms of the SNPs in the 5’-UTR of DEFB1, it was 
reported that -44 C/G was not associated with early-onset periodontitis (43) and that -20 
G/A was not associated with severe chronic periodontitis (32).  In the case of LTF-SNP, 
Lys/Arg polymorphism was shown to be associated with aggressive periodontitis (34, 
35).  In this study, we provided the first evidence that the -44 CC genotype of DEFB1 
was associated with severe chronic periodontitis and severe/moderate-combined 
periodontitis (odds ratios of 4.154 and 4.038, respectively), whereas there was no 
association with aggressive periodontitis.  This result is similar to a previous report 
that showed that the -44 C/G polymorphism was not associated with aggressive 
periodontitis (43). 
The present finding that the -44 CC genotype is associated with chronic periodontitis 
may be linked to the low expression of -defensin-1 in gingival tissue because basal 
levels of -defensin-1 reflect a protective ability in localized tissues (44, 45).  Our 
result suggests that the -44 C/G polymorphism may affect -defensin-1 expression in 
gingival tissue and enhance the disease susceptibility to chronic periodontitis.  It has 
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been reported that the constitutive human -defensin-1 mRNA level was lower in 
primary gingival keratinocytes associated with the -44 CC genotype than in cells 
associated with the -44 GG and -44 GC genotypes, and that the -44 G allele was 
associated with an increase in constitutive antimicrobial activity and expression of 
-defensin-1 (46).  Recent study concerning lepromatous leprosy demonstrated that 
position -44 is included in the putative NFB binding site and the variant could change 
the NFB binding affinity and thus influence the regulation of DEFB1 gene expression 
at the transcription stage (38).  Furthermore, several reports showed the homology 
score between the region from positions -57 to -15 of DEFB1 and the NFB binding 
site, and the value for the -44 C allele was shown to be lower than that for the -44 G 
allele (homology scores of 64.5% and 69.8%, respectively), indicating that the -44 C/G 
polymorphism could contribute to susceptibility to infectious disease (38, 47, 48).  Our 
finding that the subjects with the -44 CC genotype exhibited low concentrations of 
-defensin-1 in GCF might be attributable to the -44 C allele being involved in a 
decrease in NFB binding affinity.  Since the association between -44 C/G 
polymorphism and NFB binding affinity is not completely understood, further study 
including gel mobility shift assay might be necessary to clarify the mechanism involved. 
The present finding that the -defensin-1 concentrations in localized PD ≤ 3 mm, unlike 
in PD ≥ 4 mm, were low in the subjects with the -44 CC genotype suggests that the -44 
CC genotype may be related to the onset of chronic periodontitis.  However, the 
subjects with the -44 CC genotype did not always suffer from chronic periodontitis 
because periodontitis is a multifactorial disease associated with not only genetic factors 
but also environmental ones. 
It is generally known that -defensins are expressed in mucosal epithelial cells and 
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keratinocytes in order to protect oral mucosal surfaces.  -defensin-1 was shown to be 
expressed constitutively in epithelial tissue, but -defensin-2, -3 and -4 were found to be 
up-regulated by proinflammatory cytokines and microorganisms (16, 21).  
-defensin-1, -2 and -3 were expressed in both inflamed and non-inflamed gingival 
tissues, whereas differential expressions were observed among tissues from healthy 
subjects, and cases of gingivitis and periodontitis (49-51).  The level of -defensin-1 
mRNA expression was low in cases of gingivitis and aggressive periodontitis, but high 
in chronic periodontitis; conversely, the level of -defensin-2 mRNA expression was 
high in aggressive periodontitis but low in chronic periodontitis (52).  From these 
findings, our result may reflect that -defensin-1 plays a role in defense of the gingival 
mucosal surface. 
In this study, we demonstrated that the -52 G/A and -20 G/A polymorphisms of 
-defensin-1 were not related to aggressive and chronic periodontitis.  This result is 
partially consistent with a previous report (32).  Although previous reports showed that 
the Lys/Arg polymorphism of lactoferrin was associated with aggressive periodontitis 
(34, 35), our result showed that there were no significant differences in the associations 
of Lys/Arg polymorphism with aggressive and chronic periodontitis.  In addition, the 
concentrations of lactoferrin in GCF did not show any differences between the subjects 
with and without the GG genotype.  It has been reported that Lys/Arg polymorphism 
of lactoferrin might change the protein sequence and give rise to reduced antimicrobial 
activity of lactoferrin (34).  However, our results showed that the Lys/Arg 
polymorphism was not related to aggressive and chronic periodontitis in Japanese 
patients.  We assume that these results might be due to ethnicity and geography 
because some reports have indicated that a Thr/Ala polymorphism at position 11 
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resulting from an A/G transition was associated with aggressive periodontitis in 
African-Americans but not in Caucasians (53). 
Taken together, we conclude that the -44 CC genotype of DEFB1 is associated with the 
susceptibility to chronic periodontitis in Japanese and that -44 C/G polymorphism can 
be a predictor of chronic periodontitis. 
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Conclusion 
The -44 CC genotype of the -defensin-1 gene (DEFB1 rs1800972) may be associated 
with susceptibility to chronic periodontitis in Japanese. 
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Figure Legends 
Figure 1.  Associations between the genotypes and concentrations of antimicrobial 
peptides in GCF samples 
  GCF samples were collected using paper strips and the volumes were quantified by a 
calibrated unit.  The contents of -defensin-1 and lactoferrin in GCF were determined 
using ELISA kits.  -defensin-1 concentrations of subjects with the CC, CG and GG 
genotypes of rs1800972 (A) and lactoferrin concentrations of subjects with the GG, AG 
and AA genotypes of rs1126478 (B) are shown as the mean ± SD.     *P  0.05 
versus control.  
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